This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
All NIHB Plan Members Ages 2 Years and Older
Managing their Type 1 and Type 2 Diabetes with Insulin
are Eligible for Dexcom G6 Coverage
Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies – Diabetes Technology & Therapeutics – August 2023
Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes – American Diabetes Association – July 17, 2023
Next-Generation Dexcom G7 CGM System Approved by Health Canada – Business Wire – July 4, 2023
At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible – Diabetes Care – May 17, 2023
A review of the Symposium: “Eureka Moments: How Real-Time Continuous Blood Glucose Monitoring (rtCGM) has Changed Our Practice” – The Diabetes Communicator (Page 11) – Winter 2023
Disparities in Hemoglobin A1c in the First Year After Diagnosis Among Youths with Type 1 Diabetes Offered Continuous Glucose Monitoring – JAMA – April 19, 2023
Mednow Launches New Virtual Diabetes Management Program in Partnership with Dexcom –The Globe and Mail – February 2, 2023
CanadaCGM.com Expert Interview with Michael C. Riddell, PhD – CanadaCGM – January 10, 2023
CanadaCGM.com Expert Interview with Dr. Alexander Abitbol, MDCM, FRCPC – CanadaCGM – December 14, 2022
ADA 2022: Spotlight on Real-World Evidence Supporting the Use of Real-Time Continuous Glucose Monitoring – CanadaCGM – November 2, 2022